Imagine harnessing the power of sound waves to heal the human body–this isn’t science fiction, it’s the reality of focused ultrasound technology. Join the conversation that explores the transformative power of this noninvasive therapy revolutionizing the treatment of nearly 180 diseases and medical conditions and giving hope to patients worldwide. Presented by the Focused Ultrasound Foundation.
All content for Curing with Sound is the property of Focused Ultrasound Foundation and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Imagine harnessing the power of sound waves to heal the human body–this isn’t science fiction, it’s the reality of focused ultrasound technology. Join the conversation that explores the transformative power of this noninvasive therapy revolutionizing the treatment of nearly 180 diseases and medical conditions and giving hope to patients worldwide. Presented by the Focused Ultrasound Foundation.
Ep27: How Histotripsy is Changing the Game: A Conversation with Zhen Xu, PhD
Curing with Sound
30 minutes 57 seconds
7 months ago
Ep27: How Histotripsy is Changing the Game: A Conversation with Zhen Xu, PhD
In this episode of Curing with Sound, Zhen Xu, PhD, the Li Ka Shing Endowed Professor of Biomedical Engineering at the University of Michigan, discusses histotripsy. Dr. Xu and her colleagues developed histotripsy, the first noninvasive, nonthermal ultrasound ablation technique that received FDA approval for liver tumor treatment in 2023. Her work has led to multiple clinical trials on histotripsy treatment for malignant and benign tumors.
Dr. Xu shares the 20-year journey from initial discovery to clinical application and highlights histotripsy's remarkable ability to mechanically break down targeted tissue without incisions or radiation. She also recounts inspiring patient stories from clinical trials, including patients who experienced no pain and returned to normal activities immediately after treatment.
Regulatory Approval: In October 2023, the FDA cleared HistoSonics’ novel therapy platform, Edison™, to treat liver tumors. Edison™ uses histotripsy to noninvasively destroy liver tissue. This is the first time the use of histotripsy has earned regulatory approval worldwide.
The Science Behind Histotripsy: Dr. Xu explains how histotripsy uses focused ultrasound pulses to rapidly expand and collapse microbubbles that break down targeted cells with remarkable precision.
Future Directions: Dr. Xu envisions continued expansion of histotripsy applications over the next five years, including wider adoption for liver tumors, regulatory approvals for additional indications, and the development of new platforms for brain and shallow tumor treatments.
Histotripsy Lab: histotripsy.umich.eduConnect on Linked In: Dr. Zhen Xu
EPISODE TRANSCRIPT----------------------------QUESTIONS?Email podcast@fusfoundation.org if you have a question or comment about the show, or if you would you like to connect about future guest appearances.
Email info@fusfoundation.org if you have questions about focused ultrasound or the Foundation.
FUSF SOCIAL MEDIA
LinkedIn
X
Facebook
Instagram
TikTok
YouTube
FUSF WEBSITEhttps://www.fusfoundation.orgSIGN UP FOR OUR FREE NEWSLETTERhttps://www.fusfoundation.org/newsletter-signup/READ THE LATEST NEWSLETTERhttps://www.fusfoundation.org/the-foundation/news-media/newsletter/DOWNLOAD "THE TUMOR" BY JOHN GRISHAM (FREE E-BOOK)https://www.fusfoundation.org/read-the-tumor-by-john-grisham/
Curing with Sound
Imagine harnessing the power of sound waves to heal the human body–this isn’t science fiction, it’s the reality of focused ultrasound technology. Join the conversation that explores the transformative power of this noninvasive therapy revolutionizing the treatment of nearly 180 diseases and medical conditions and giving hope to patients worldwide. Presented by the Focused Ultrasound Foundation.
